The FDA authorizes a new type of cholesterol medication

| |

Americans struggling to lower their cholesterol will have another medication at their disposal, after the U.S. Food and Drug Administration. UU. Approved a new medication from Esperion Therapeutics Inc.

The Esperion pill, once a day, bempedoic acid, is the first oral non-statin approved in almost two decades. The medication works differently than others to reduce bad cholesterol, LDL, and eventually forces it out of the patient’s bloodstream. Doctors see the drug as an alternative for millions of patients who cannot take or do not respond to statins, a …

.

Previous

The Astros can’t steal Clayton Kershaw’s love for baseball

Nevada Caucus: the first test of a diverse electorate

Next

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.